Publications of Eoin Molloy

Beinhölzl, N.; Molloy, E.; Zsido, R.; Richter, T.; Piecha, F. A.; Zheleva, G.; Scharrer, U.; Regenthal, R.; Villringer, A.; Okon-Singer, H. et al.; Sacher, J.: The attention-emotion interaction in healthy female participants on oral contraceptives during 1-week escitalopram intake. Frontiers in Neuroscience 16, 809269 (2022)

Zsido, R.; Molloy, E.; Cesnaite, E.; Zheleva, G.; Beinhölzl, N.; Scharrer, U.; Piecha, F. A.; Regenthal, R.; Villringer, A.; Nikulin, V. V. et al.; Sacher, J.: One-week escitalopram intake alters the excitation-inhibition balance in the healthy female brain. Human Brain Mapping 43 (6), pp. 1868 - 1881 (2022)

Molloy, E.; Zsido, R.; Piecha, F. A.; Beinhölzl, N.; Scharrer, U.; Zheleva, G.; Regenthal, R.; Sehm, B.; Nikulin, V. V.; Möller, H. E. et al.; Villringer, A.; Sacher, J.; Mueller, K.: Decreased thalamo-cortico connectivity during an implicit sequence motor learning task and 7 days escitalopram intake. Scientific Reports 11 (1), 15060 (2021)

Molloy, E.; Mueller, K.; Beinhölzl, N.; Blöchl, M.; Piecha, F. A.; Pampel, A.; Steele, C.; Scharrer, U.; Zheleva, G.; Regenthal, R. et al.; Sehm, B.; Nikulin, V. V.; Möller, H. E.; Villringer, A.; Sacher, J.: Modulation of premotor cortex response to sequence motor learning during escitalopram intake. Journal of Cerebral Blood Flow and Metabolism 41 (6), pp. 1449 - 1462 (2021)

Beinhölzl, N.; Molloy, E.; Zsido, R.; Richter, T.; Piecha, F. A.; Zheleva, G.; Scharrer, U.; Regenthal, R.; Villringer, A.; Okon-Singer, H. et al.; Sacher, J.: One-week of escitalopram administration does not change emotional and attentional responses in healthy female individuals on oral hormonal contraceptives. In European Neuropsychopharmacology, 53 (Suppl. 1), pp. S603 - S604. Elsevier, Amsterdam (2021)

Zsido, R.; Molloy, E.; Cesnaite, E.; Zheleva, G.; Scharrer, U.; Regenthal, R.; Villringer, A.; Nikulin, V. V.; Sacher, J.: One-week escitalopram intake alters excitation-inhibition balance in healthy female participants: Implications for neuroplasticity and individual SSRI responsivity. In Neuropsychopharmacology, 45 (Suppl. 1), pp. 324 - 325. Springer Nature, New York, NY (2020)

Molloy, E.; Möller, H. E.; Regenthal, R.; Villringer, A.; Sacher, J.; Mueller, K.: Altered functional connectivity during combined sequential motor learning and one-week escitalopram administration. In European Neuropsychopharmacology, 40 (Suppl. 1), pp. S252 - S253. 33rd European College of Neuropsychopharmacology Congress (ECNP 2020) , September 12, 2020 - September 15, 2020. Elsevier, Amsterdam (2020)

Beinhölzl, N.; Naor, N.; Okon-Singer, H.; Buchenau, A.; Scharrer, U.; Molloy, E.; Villringer, A.; Sacher, J.: A novel social perception task for testing thesocial interaction model in pharmaco-fMRIprotocols with selective serotonin reuptakeinhibitors. In European Neuropsychopharmacology, 27 (Suppl. 4), pp. S718 - S719. Elsevier, Amsterdam (2017)

Molloy, E.; Mueller, K.; Sehm, B.; Kanaan, A. S.; Pampel, A.; Steele, C.; Nikulin, V. V.; Bazin, P.-L.; Beinhölzl, N.; Zheleva, G. et al.; Piecha, F.; Ihle, K.; Blöchl, M.; Scharrer, U.; Regenthal, R.; Möller, H. E.; Villringer, A.; Sacher, J.: Serotonergic modulation of behavioural and neural responses during motor learning. 2019 OHBM Annual Meeting, Rome, Italy (2019)

Beinhölzl, N.; Molloy, E.; Richter, T.; Zheleva, G.; Piecha, F.; Scharrer, U.; Regenthal, R.; Villringer, A.; Okon-Singer, H.; Sacher, J.: No effect of escitalopram on cognition during an emotional distractor task: A randomised, placebo-controlled clinical study. 9th IMPRS NeuroCom Summer School, Leipzig, Germany (2019)

Zheleva, G.; Zsido, R.; Molloy, E.; Cesnaite, E.; Beinhölzl, N.; Scharrer, U.; Nikulin, V. V.; Regenthal, R.; Villringer, A.; Sacher, J.: The effects of subacute escitalopram administration on resting state EEG in a sample of healthy females. 9th IMPRS NeuroCom Summer School, Leipzig, Germany (2019)

Beinhölzl, N.; Noar, N.; Okon-Singer, H.; Buchenau, A.; Scharrer, U.; Molloy, E.; Backhausen, L.; Villringer, A.; Sacher, J.: A novel social perception task for testing the social interaction model in pharmaco-fMRI protocols with selective serotonin reuptake inhibitors. 30th European College of Neuropsychopharmacology Congress, Paris, France (2017)